ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,969,299 | -32.5% | 24,950 | +1.1% | 0.03% | -26.1% |
| Q2 2023 | $4,396,304 | +7.4% | 24,672 | -0.6% | 0.05% | +4.5% |
| Q1 2023 | $4,094,472 | +4.7% | 24,821 | -0.0% | 0.04% | +4.8% |
| Q4 2022 | $3,910,228 | +4.4% | 24,830 | -0.2% | 0.04% | -4.5% |
| Q3 2022 | $3,747,000 | -9.3% | 24,878 | -1.0% | 0.04% | -2.2% |
| Q2 2022 | $4,129,000 | -27.2% | 25,117 | -1.4% | 0.04% | -11.8% |
| Q1 2022 | $5,671,000 | -5.6% | 25,470 | +0.6% | 0.05% | 0.0% |
| Q4 2021 | $6,010,000 | -1.8% | 25,324 | -3.4% | 0.05% | -5.6% |
| Q3 2021 | $6,120,000 | -10.9% | 26,224 | -21.4% | 0.05% | -6.9% |
| Q2 2021 | $6,869,000 | -0.8% | 33,375 | -1.0% | 0.06% | -4.9% |
| Q1 2021 | $6,924,000 | -9.7% | 33,705 | -5.8% | 0.06% | -15.3% |
| Q4 2020 | $7,671,000 | +13.4% | 35,763 | -3.4% | 0.07% | -4.0% |
| Q3 2020 | $6,767,000 | +5.5% | 37,025 | +6.3% | 0.08% | +2.7% |
| Q2 2020 | $6,417,000 | -19.8% | 34,819 | -12.2% | 0.07% | -23.2% |
| Q1 2020 | $8,003,000 | +8.7% | 39,666 | +0.8% | 0.10% | +61.0% |
| Q4 2019 | $7,363,000 | +17.6% | 39,350 | +0.3% | 0.06% | +13.5% |
| Q3 2019 | $6,261,000 | -34.5% | 39,230 | +3.3% | 0.05% | -28.8% |
| Q2 2019 | $9,564,000 | +11.8% | 37,965 | +6.2% | 0.07% | +12.3% |
| Q1 2019 | $8,557,000 | +4.2% | 35,754 | 0.0% | 0.06% | -5.8% |
| Q4 2018 | $8,210,000 | -16.6% | 35,754 | +2.7% | 0.07% | +3.0% |
| Q3 2018 | $9,847,000 | -14.2% | 34,825 | -10.9% | 0.07% | -14.1% |
| Q2 2018 | $11,474,000 | -28.9% | 39,075 | -38.8% | 0.08% | -28.4% |
| Q1 2018 | $16,128,000 | +14.3% | 63,900 | -2.1% | 0.11% | +23.9% |
| Q4 2017 | $14,105,000 | +16.2% | 65,300 | 0.0% | 0.09% | +17.3% |
| Q3 2017 | $12,136,000 | +3.8% | 65,300 | -3.7% | 0.08% | 0.0% |
| Q2 2017 | $11,696,000 | +11.7% | 67,800 | -1.2% | 0.08% | +13.6% |
| Q1 2017 | $10,475,000 | +1.0% | 68,600 | -2.6% | 0.07% | 0.0% |
| Q4 2016 | $10,373,000 | +16.4% | 70,400 | -0.1% | 0.07% | +13.8% |
| Q3 2016 | $8,910,000 | +12.1% | 70,500 | 0.0% | 0.06% | +9.4% |
| Q2 2016 | $7,949,000 | +8.3% | 70,500 | 0.0% | 0.05% | +10.4% |
| Q1 2016 | $7,339,000 | -7.7% | 70,500 | 0.0% | 0.05% | -7.7% |
| Q4 2015 | $7,951,000 | +1.3% | 70,500 | -1.7% | 0.05% | 0.0% |
| Q3 2015 | $7,851,000 | +11.4% | 71,700 | -2.7% | 0.05% | +36.8% |
| Q2 2015 | $7,050,000 | -23.3% | 73,700 | -25.3% | 0.04% | -20.8% |
| Q1 2015 | $9,193,000 | -0.9% | 98,700 | -12.9% | 0.05% | 0.0% |
| Q4 2014 | $9,279,000 | +18.3% | 113,300 | -7.3% | 0.05% | +14.3% |
| Q3 2014 | $7,843,000 | +2.7% | 122,200 | -2.7% | 0.04% | +5.0% |
| Q2 2014 | $7,638,000 | +10.9% | 125,600 | +9.2% | 0.04% | +8.1% |
| Q1 2014 | $6,886,000 | +55.0% | 115,000 | +64.9% | 0.04% | +54.2% |
| Q4 2013 | $4,443,000 | +36.2% | 69,733 | +45.2% | 0.02% | +26.3% |
| Q3 2013 | $3,263,000 | +65.6% | 48,033 | +75.7% | 0.02% | +58.3% |
| Q2 2013 | $1,970,000 | – | 27,333 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |